Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Webcast, Proxy/Proxy Vote

ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders


ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced log-in details for its 2021 Virtual Annual Meeting of Stockholders to be held on June 2, 2021, beginning at 10 a.m. Eastern Time.

Stockholders can attend the virtual annual meeting via the internet at www.virtualshareholdermeeting.com/ANIP2021. Stockholders of record as of the close of business on April 26, 2021 will be eligible to vote their shares and submit questions electronically in advance of and during the virtual annual meeting by using the 16-digit control number included on their individual proxy card or on the voting instruction form accompanying the proxy materials to attend the annual meeting. Stockholders may begin to log in to the meeting platform beginning at 9:45 a.m. Eastern Time on June 2, 2021. We recommend that stockholders log in at that time to ensure they are logged in when the meeting starts.

A replay of the meeting will be available for one year following the meeting date. To listen to a replay of the annual meeting, please visit www.virtualshareholdermeeting.com/ANIP2021.

About ANI

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The Company's targeted areas of product development currently include narcotics, oncolytics (anti-cancers), hormones and steroids, and complex formulations involving extended release and combination products. For more information, please visit our website www.anipharmaceuticals.com.


These press releases may also interest you

at 09:13
Methodist Le Bonheur Healthcare announced Methodist University Hospital earned top recognition by Money magazine as one of the Best U.S. Hospitals for Cardiac Care. The Memphis-based healthcare system's academic flagship landed 15th out of 75 and is...

at 09:06
Avicenna.AI, a leading medical imaging AI company, has received Medical Device Regulation (MDR) certificate for five of its algorithms from certification body BSI Medical Devices. This development means the company's product portfolio is fully...

at 09:03
Insmed Incorporated , a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that additional positive results from the ASPEN...

at 09:00
In March 2024, dairy cows in Texas were found to be infected with highly pathogenic avian flu, or H5N1 bird flu, in the first known case of the virus spreading to cattle. Since then, H5N1 has been found in about 200 animals?and 3 people?across 12...

at 09:00
Emmaus Life Sciences, Inc. , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the year ended December 31, 2023....

at 09:00
Global health company The Cigna Group will release its second quarter 2024 financial results on Thursday, August 1, 2024, and will host a conference call the same day....



News published on and distributed by: